Raymond James Financial Services Advisors, Inc. Aim Immuno Tech Inc. Transaction History

Raymond James Financial Services Advisors, Inc.

  • $73.5 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Oct 25, 2022
SELL
$0.57 - $0.81 $285 - $405
-500 Reduced 1.34%
36,950 $22,000
Q2 2022

Aug 12, 2022
BUY
$0.78 - $1.27 $29,211 - $47,561
37,450 New
37,450 $29,000
Q1 2022

May 11, 2022
SELL
$0.67 - $1.18 $32,461 - $57,171
-48,450 Closed
0 $0
Q3 2021

Nov 02, 2021
BUY
$1.91 - $2.17 $955 - $1,085
500 Added 1.04%
48,450 $98,000
Q2 2021

Aug 11, 2021
BUY
$1.93 - $2.39 $92,543 - $114,600
47,950 New
47,950 $103,000

Others Institutions Holding AIM

# of Institutions
36
Shares Held
9.01M
Call Options Held
0
Put Options Held
0
View Full List

About AIM ImmunoTech Inc.

AIM Quotes by TradingView
  • Ticker AIM
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,049,300
  • Market Cap $11.1M
  • Description
  • AIM ImmunoTech Inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers, viral diseases, and immune-deficiency disorders in the United States. The company's products include Ampligen, a drug of macromolecular ribonucleic acid molecules for the treatment of chronic fatigue syndrome...
More about AIM
Track This Portfolio

Track Raymond James Financial Services Advisors, Inc. Portfolio

Follow Raymond James Financial Services Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James Financial Services Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Raymond James Financial Services Advisors, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email